Imbali yethu

 

 

 
2016

•Yasekwa eHangzhou, eChina

 
2017

•Kufunyanwe imvume yolawulo kwisizukulwana sokuqala{0}}imveliso yoxilongo olukhawulezayo lwezilwanyana zasekhaya.

 
2018

• Yandisiwe kwiimarike zamazwe ngamazwe nge-bio{0}}izisombululo zokuxilonga.

 
2019

• Ukuphehlelelwa ngokusesikweni iimveliso zovavanyo olukhawulezileyo lwemfuyo

 
2021-2022

•Iziko le-R&D eligqityiweyo, iSebe le-QA/QC, kunye neGMP-indawo yokuvelisa eqinisekisiweyo.

 
2022.3

• Kuphunyezwe isiqinisekiso se-ISO 9001

• Ivunyiwe njengeLebhu yeNqanaba le-Biosafety II.

 
2022.4

• Kuqaliswe inkqubo yeR&D yoxilongo lwezilwanyana zasekhaya ezingaqhelekanga.

•Wavula icwecwe lokuqala lehlabathi lovavanyo lwe-Cryptosporidium antigen kwizirhubuluzi.

 
2022.5

• Waba lilungu le-China Veterinary Medical Association

 
2022.12

• Iimveliso zohlobo lweVD ezisasazwe kumazwe 40+.

• Secured >I-60% yesabelo semarike kwimimandla ebalulekileyo.

 
2023.2

•Yasekwa CHENGDU EVEGEN BIOTECH CO., LTD ukomeleza imveliso kunye nolungiselelo.

 
2023.6

• Ujoyine i-China Veterinary Drug Association.

 
2023.7

• Ufumene iziqinisekiso ze-ISO 14001 kunye ne-ISO 45001.

• Isebe leChengdu lifumene ilayisensi yeGSP yonyango lwezilwanyana.

 
2023.9

• Ufumene ipatent kwiFeline Herpesvirus Type 1 (FHV-1)

• Ufumene ipatent yeEquine Infectious Anemia Virus

 
2024.10

• Ufumene ipatent kuVavanyo lweLeishmania Antibody

 
2025.1

• Ufumene ipatent kwiCanine Leishmania

 
2025.3

• Ufumene ipatent kwi anti{0}}ETEC K99 monoclonal antibody